• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Evaluating the risk of SARS-CoV-2 reinfection with the Omicron or Delta variant in Wales, UK

tetano

Editor, Senior Moderator
PLoS One


. 2024 Sep 6;19(9):e0309645.
doi: 10.1371/journal.pone.0309645. eCollection 2024. Evaluating the risk of SARS-CoV-2 reinfection with the Omicron or Delta variant in Wales, UK

Mark Postans[SUP] 1 [/SUP], Nicole Pacchiarini[SUP] 1 [/SUP], Jiao Song[SUP] 1 [/SUP], Simon Cottrell[SUP] 1 [/SUP], Catie Williams[SUP] 2 [/SUP], Andrew Beazer[SUP] 2 [/SUP], Catherine Moore[SUP] 3 [/SUP], Thomas R Connor[SUP] 2 4 [/SUP], Christopher Williams[SUP] 1 [/SUP]



Affiliations
Abstract

Recent studies suggest an increased risk of reinfection with the SARS-CoV-2 Omicron variant compared with previous variants, potentially due to an increased ability to escape immunity specific to older variants, high antigenic divergence of Omicron from earlier virus variants as well as its altered cell entry pathway. The present study sought to investigate epidemiological evidence for differential SARS-CoV-2 reinfection intervals and incidence rates for the Delta versus Omicron variants within Wales. Reinfections in Wales up to February 2022 were defined using genotyping and whole genome sequencing. The median inter-infection intervals for Delta and Omicron were 226 and 192 days, respectively. An incidence rate ratio of 2.17 for reinfection with Omicron compared to Delta was estimated using a conditional Poisson model, which accounted for several factors including sample collection date, age group, area of residence, vaccination and travel status. These findings are consistent with an increased risk of reinfection with the Omicron variant, and highlight the value of monitoring emerging variants that have the potential for causing further waves of cases.


 
Back
Top Bottom